SEC Filing Analysis: Avidity Biosciences, Inc. (RNA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Technical Officer acquired shares through the vesting of performance-based restricted stock units (PSUs), with a portion automatically sold to cover tax liabilities. This is a routine, non-discretionary compensation event.
• Market Impact: The transaction is negligible relative to the company's market capitalization and is unlikely to influence the stock price.

Company Information

Field	Value
Company	Avidity Biosciences, Inc.
Ticker Symbol	RNA
CIK	0001599901
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Calderaro Charles III
CIK	0002049888
Title/Position	Chief Technical Officer
Relationship	Officer

Transaction Details

This filing reports two transactions: an acquisition via PSU vesting and a disposition to cover taxes.

Transaction 1: Acquisition

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	A (Award)
Security Type	Common Stock
Shares Involved	23,250
Price Per Share	$0.00
Total Value	$0
Ownership Type	Direct

Transaction 2: Tax Withholding

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	F (Payment of tax liability by withholding)
Security Type	Common Stock
Shares Involved	9,726
Price Per Share	$71.87
Total Value	$699,041.22
Ownership Type	Direct

Final Shares Owned After Both Transactions: 53,524

Financial Impact Assessment

Transaction Materiality

Metric	Value
Value of Acquired Shares (at market price)	~$1,670,898
% of Market Cap	0.016%
Shares Transacted (Net)	+13,524
% of Shares Outstanding	Not Available
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Avidity Biosciences has a market capitalization of $10.67 billion. The total value of the vested shares (~$1.67M) is insignificant, representing only 0.016% of the company's market value.
• Ownership Concentration: Without data on shares outstanding, a precise ownership percentage cannot be calculated. However, the transaction itself is related to compensation and not a significant shift in ownership strategy.
• Dilution Impact: The issuance of 23,250 shares is from a previously disclosed PSU grant. The dilutive impact is minimal and was likely priced in by the market when the original grant was announced.
• Transaction Significance: The event is a standard part of an executive compensation package. The vesting of PSUs and the subsequent automatic sale for taxes do not provide new information about the insider's view of the company's future prospects.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a non-discretionary transaction related to executive compensation. It does not signal a change in insider sentiment and is too small to have a market impact.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to affect trading volume.
• Sentiment Indicator: Neutral. The market generally views PSU vesting and tax-related sales as routine and non-indicative.

Additional Context

Transaction Notes

• Special Circumstances: As noted in the filing's footnotes, the primary transaction was the vesting of Performance-Based Restricted Stock Units (PSUs). The secondary transaction was an automatic withholding of shares by the issuer to satisfy tax obligations, which is not a discretionary sale by the insider.